Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03238586 · ClinicalTrials.gov registry record · NA
HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions
A NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
NCT03238586 is a NA study that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 232 participants.
The verdict
NCT03238586, a NA study, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
Study Summary
A clinical study for patients with HIV that investigates the best way to reduce HIV transmission risk, and to improve the overall health of people living with HIV/AIDS. Participants will complete four assessments over the course of one year and will be randomly assigned to a five-week treatment program.
Interventions
- BEHAVIORAL WELL Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2012-11 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03238586
The ClinicalTrials.gov registry entry for NCT03238586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WELL Program is the first listed.
NCT03238586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03238586 about?
NCT03238586 is a clinical study titled "HIV/AIDS & Alcohol-Related Outcomes: Translational Evidence-Based Interventions". A clinical study for patients with HIV that investigates the best way to reduce HIV transmission risk, and to improve the overall health of people living with HIV/AIDS. Participants will complete four assessments over the course of one year and will be randomly assigned to a five-week treatment prog...
What is the current status of trial NCT03238586?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2012-11. Estimated completion is 2019-08.
What interventions are being tested in trial NCT03238586?
The interventions under investigation include: WELL Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03238586?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.